{"nct_id":"NCT02955550","title":"A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2017-01-05","start_date_type":"ACTUAL","primary_completion_date":"2018-07-10","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CELU"]}